Senior insider sale
Chief Scientific Officer at TOURMALINE BIO, INC. — senior position signals high conviction
$556.0K
255.10K shares
ILDSTAD SUZANNE plans to sell 255.10K shares of TOURMALINE BIO, INC. valued at approximately $556.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Founders Shares
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/30/2018 | Founders Shares N/A | 10.05K | — |
| Total | 10.05K | ||
Completed
Units to sell
46.99K
Market value
$109.3K
Units to sell
21.75K
Market value
$47.1K
Units to sell
49.21K
Market value
$105.8K
Units to sell
99.77K
Market value
$213.5K
Units to sell
10.44K
Market value
$21.5K
Units to sell
6.81K
Market value
$14.0K
Units to sell
29.00
Market value
$59.45
Units to sell
3.50K
Market value
$7.2K
Units to sell
3.61K
Market value
$7.4K
Units to sell
2.94K
Market value
$6.0K
Planned — Approximate Date
Units to sell
10.05K
Market value
$24.0K
Units
255.10K
Value
$556.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
4/20/2023 | 46.99K | $109.3K | — | Completed |
4/19/2023 | 21.75K | $47.1K | — | Completed |
4/18/2023 | 49.21K | $105.8K | — | Completed |
4/17/2023 | 99.77K | $213.5K | — | Completed |
3/17/2023 | 10.44K | $21.5K | — | Completed |
3/3/2023 | 6.81K | $14.0K | — | Completed |
3/1/2023 | 29.00 | $59.45 | — | Completed |
2/21/2023 | 3.50K | $7.2K | — | Completed |
2/17/2023 | 3.61K | $7.4K | — | Completed |
2/16/2023 | 2.94K | $6.0K | — | Completed |
| Planned — Approximate Date | ||||
4/21/2023 | 10.05K | $24.0K | NASDAQ | Planned |
| Total | 255.10K | $556.0K | ||